- Home
- NN vs HRMY Comparison
NN vs HRMY Comparison
Compare NN & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NN
- HRMY
- Stock Information
- Founded
- NN 2007
- HRMY 2017
- Country
- NN United States
- HRMY United States
- Employees
- NN N/A
- HRMY N/A
- Industry
- NN Industrial Machinery/Components
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- NN Industrials
- HRMY Health Care
- Exchange
- NN Nasdaq
- HRMY Nasdaq
- Market Cap
- NN 2.2B
- HRMY 2.2B
- IPO Year
- NN N/A
- HRMY 2020
- Fundamental
- Price
- NN $11.80
- HRMY $34.56
- Analyst Decision
- NN
- HRMY Strong Buy
- Analyst Count
- NN 0
- HRMY 8
- Target Price
- NN N/A
- HRMY $54.38
- AVG Volume (30 Days)
- NN 913.8K
- HRMY 557.4K
- Earning Date
- NN 03-12-2025
- HRMY 02-25-2025
- Dividend Yield
- NN N/A
- HRMY N/A
- EPS Growth
- NN N/A
- HRMY N/A
- EPS
- NN N/A
- HRMY 2.11
- Revenue
- NN $4,963,000.00
- HRMY $681,879,000.00
- Revenue This Year
- NN $46.32
- HRMY $25.11
- Revenue Next Year
- NN $43.50
- HRMY $19.19
- P/E Ratio
- NN N/A
- HRMY $16.46
- Revenue Growth
- NN 43.44
- HRMY 25.83
- 52 Week Low
- NN $3.55
- HRMY $28.14
- 52 Week High
- NN $18.54
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- NN 42.54
- HRMY 35.54
- Support Level
- NN $11.44
- HRMY $37.03
- Resistance Level
- NN $13.12
- HRMY $39.91
- Average True Range (ATR)
- NN 0.65
- HRMY 1.34
- MACD
- NN 0.12
- HRMY -0.58
- Stochastic Oscillator
- NN 25.31
- HRMY 9.86
About NN NextNav Inc.
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation and Timing services in the absence of GPS.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.